Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Nov 19;117(10):1178-82.

Long-term treatment of severe hypertension with minoxidil

Long-term treatment of severe hypertension with minoxidil

T Nawar et al. Can Med Assoc J. .

Abstract

Minoxidil, a new potent hypotensive agent, was used as the primary antihypertensive agent in 11 patients--10 men and 1 woman aged 35 to 54 years with severe hypertension that was refractory to treatment with maximal (or maximally tolerated) doses of conventional antihypertensive agents. Six patients had severely impaired renal function and three of them were undergoing long-term hemodialysis. The patients were given 2.5 to 40 mg/d of minoxidil for periods of 2 to 29 months. All except one who was almost anuric received propranolol and diuretics. Blood pressure was controlled satisfactorily in all patients. In two patients the hypertension became partially resistant after 1 year of treatment. The main side effects were sodium retention, tachycardia and hirsutism. Renal function remained stable or improved and hemodialysis was discontinued in two patients. Minoxidil is a remarkably potent hypotensive with relatively few side effects and seems particularly advantageous in patients with chronic renal failure.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pediatr. 1977 May;90(5):813-9 - PubMed
    1. J Clin Pharmacol. 1976 Oct;16(10 Pt 1):498-509 - PubMed
    1. J Pharmacol Exp Ther. 1973 Mar;184(3):662-70 - PubMed
    1. N Engl J Med. 1973 Jul 26;289(4):167-71 - PubMed
    1. Am J Med Sci. 1969 Jan;257(1):9-23 - PubMed

LinkOut - more resources